Eylea 8 mg pre-filled syringe approved in the EU – Bayer
The European Medicines Agency (EMA) has approved the pre-filled syringe for the administration of Eylea™ 8 mg (114.3 mg/ml solution for injection) in the European Union. The new… read more.
The European Medicines Agency (EMA) has approved the pre-filled syringe for the administration of Eylea™ 8 mg (114.3 mg/ml solution for injection) in the European Union. The new… read more.
Hypertonic saline (HS) nasal drop treatment can reduce by two days the length of the common cold in children, researchers reported on September 6. 2024 at the European… read more.
A new study reveals that young patients treated with psychiatric medications receive potentially dangerous combinations with concerning frequency. Researchers from Rutgers Health and other institutions analyzed New York… read more.
The OpioidHALT intervention is tailored to the needs of individual patients and evaluated for safety by a pain specialist. Shared decision-making, with the patient, is an important feature… read more.
Gilead Sciences, Inc. announced that the FDA has granted accelerated approval for Livdelzi (seladelpar) for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA)… read more.
Over-the-counter blood pressure measuring devices offer a simple, affordable way for people to track hypertension at home, but the standard arm-size ranges for these devices won’t appropriately fit… read more.
FIP’s Early Career in Pharmaceutical Practice Recognition Award recognises an outstanding early career pharmacist who has made significant contributions to the field at a national level and is… read more.
Opioid doses can be successfully reduced by a pharmacy-led intervention, according to a randomised study led by Dr Shania Liu and Dr Jonathan Penm at the University of… read more.
Avadel Pharmaceuticals plc , announced the publication of final data from the RESTORE open-label/switch study, demonstrating that people with narcolepsy prefer once-at-bedtime Lumryz versus a twice-nightly immediate-release oxybate… read more.
According to research presented at ESC Congress 2024,1 women with endometriosis have a 20% greater risk of significant cardiac outcomes compared with women without endometriosis. “For decades, cardiovascular… read more.
Using hypertonic saline nasal drops can reduce the length of the common cold in children by two days, according to a study that will be presented at the… read more.
Catheter Precision, Inc. announced that at the recently held European Society of Cardiology (ESC) Symposium, interim results demonstrating the use of VIVO in localizing the site of origin… read more.